BY THE OPTIMIST DAILY EDITORIAL TEAM
A breakthrough in vitiligo treatment may offer hope to millions affected by the skin condition. Researchers at Northwestern University have developed an experimental therapy using beneficial gut bacteria, showing significant potential in reversing the disease—at least in mice.
Vitiligo is an autoimmune disorder where the body’s own immune cells attack melanocytes, the cells responsible for producing skin pigment. This leads to patchy skin discoloration, which, while not harmful, can have a profound psychological impact on those affected.
Although treatments like steroid creams exist, they often come with side effects and varying levels of success. Researchers, however, have now turned to a natural solution: beneficial gut bacteria.
The power of probiotics
Scientists have found that people with vitiligo tend to have an imbalance in skin bacteria. Harmful microbes like Streptococcus thrive, while probiotic bacteria, which protect melanocytes, are lacking. With this in mind, the researchers looked to Bacillus subtilis, a common probiotic found in the gut and soil.
By genetically modifying Bacillus subtilis, they increased its production of exopolysaccharides (EPS)—compounds known to reduce immune overreactions. This modified strain was then tested in mice with vitiligo, with astonishing results.
Significant improvement in vitiligo symptoms
The study involved treating vitiligo-prone mice with weekly EPS injections over 18 weeks. The results were dramatic: treated mice showed a 74 percent reduction in pigment loss, while the control group (which received no treatment) saw no improvement.
Further analysis revealed a 63.6 percent decrease in cytotoxic T cells, which are responsible for attacking melanocytes, and a 1.7-fold increase in regulatory T cells, which protect melanocytes from destruction.
“The results in our model were astonishing,” said Prof. I. Caroline Le Poole, senior author of the study. “We found that administering a microbial compound weekly to vitiligo-prone mice significantly suppressed disease progression. It made a spectacular difference in an aggressive model of the disease.”
A future treatment for humans?
While the research is still in its early stages, the findings suggest that probiotic-based therapies could revolutionize vitiligo treatment. Scientists are now exploring ways to apply this therapy to humans, potentially developing a topical ointment or even a food additive instead of relying on weekly injections.
With millions of people worldwide seeking more effective vitiligo treatments, this research marks an exciting step forward. Further clinical trials will determine how long the effects last and how this therapy can be safely adapted for human use.
Source study: Journal of Investigative Dermatology—Bacillus Subtilis–derived exopolysaccharide halts depigmentation and autoimmunity in vitiligo
